Zevra Therapeutics Inc (ZVRA) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

By Yahoo! Finance   |   1 month ago
Zevra Therapeutics Inc (ZVRA) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

The company plans to file a marketing authorization application for MyPIFA in Europe in the second half of 2025, targeting the mature European market with a significant opportunity. The conservative cash runway guidance excludes potential European approval and focuses on current plans without factoring in the voucher sale proceeds.

Read More

Did you find this insightful?